Recent study investigated how fast genes are being transferred between distantly related species.
The biotech sector uses climate change as an urgent argument for more funding and fewer regulatory hurdles. But the urgency of climate change raises the risk of superficial claims and actions.
Recent successes putting genetically modified pig organs into people have brought xenotransplantation back into the spotlight.
New developments in organ transplants from animals show promise. However, there has been no public engagement about a potential risk. It may streamline a pathway to humans for new zoonotic diseases.
Field trials of genetically edited crop plants are to be allowed in England under new government proposals.
GM proponents say the technology leads to better crop yields and may solve food shortages and reduce pests. Opponents say GM is a threat to the environment and humans. So where does the truth lie?
If species already modify their genes, why shouldn’t we?
The answer lies in determining what we are and what we want to become.
Genetically modified mosquitoes were released in Brazil in an attempt to halt the spread of dengue fever by reducing the mosquito population.
South Australia has lifted its moratorium on GM crops, while Tasmania has extended its ban. But the question should no longer be a simple binary of being “for” or “against” GM technology.
Mosquitoes love sugar – so much so that can delay their search for our blood. Now, their sweet tooth may have revealed an important genetic weapon against the spread of mosquito-borne disease.
Scientists are in a race to genetically engineer a new plant resistant to a devastating disease that is threatening to wipe out the banana.
The fight against malaria needs scientific innovation. But community buy-in is just as important.
Synthetic biology is highly promising – but if we don’t get the regulation and engagement right, we risk alienating members of the public, and may even close doors for potentially fruitful research.
Genetic modification rules now cover gene edited crops but exclude plants bred traditionally with the same properties.
Two researchers are impressed with a pioneering study showing that it may be both safe and effective to edit out diseases in human embryos.
William Isdale talks to Professor Julian Savulescu about the ethical implications of geneticaly modifying humans.
William Isdale speaks with University of Queensland Professor Peter Koopman about CRISPR technology.
Researchers are starting to harness the potential of this much-hyped gene editing technique – with coming applications in medicine, biology and agriculture.
A broad process of communication and consultation should be initiated before gene drives are applied to control pests and diseases in Australia.